Botulinum Toxin Type A (HengLi)

botulinum toxin type A · Lanzhou Institute of Biological Products Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Botulinum Toxin Type A (HengLi), covering 2018-01-03 to 2018-01-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine [Phase 3]

See pricing